Align Technology Inc header image

Align Technology Inc

ALGN

Equity

ISIN US0162551016 / Valor 1159441

NASDAQ (2024-09-18)
USD 253.01-0.06%

Align Technology Inc
UMushroom community rating:

star star star star star
4.50 2 votes No rating yet
NegativeNeutralPositive

About company

Align Technology Inc is a global leader in the dental CAD/CAM software market, offering fully integrated workflows to dental labs and practices through a wide network of partners and resellers in over 150 countries. The company's digital scanning technology, including the iTero intraoral scanner, complements its Invisalign system, enhancing patient scans and overall experience. Align Technology continues to invest in digital restorative workflows, with over 17 million restorative cases enabled by the iTero scanner to date. Additionally, the company provides a range of digitally enabled solutions for restorative dentistry, orthodontic treatment, and other dental applications. With a focus on innovation and customer satisfaction, Align Technology remains a leading provider of advanced clear aligner systems and digital orthodontic solutions worldwide.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (28.05.2024):

Q1'24 Revenue Growth

Align Technology Inc. reported a total revenue of $997.4 million in the first quarter of 2024, marking a 5.8% increase year-over-year. This growth includes a 3.5% increase in revenue from Clear Aligners and a significant 17.5% increase from Imaging Systems and CAD/CAM Services.

Q1'24 Earnings Per Share

For Q1'24, Align Technology Inc. achieved a diluted net income per share of $1.39. On a non-GAAP basis, the diluted net income per share was higher at $2.14, reflecting adjustments for certain non-recurring items.

Q1'24 Operating Income and Margin

Align Technology Inc. recorded an operating income of $154.1 million in Q1'24, with an operating margin of 15.5%. The non-GAAP operating margin was notably higher at 19.8%, indicating effective cost management and operational efficiency.

Q1'24 Clear Aligner Performance

The Clear Aligner segment of Align Technology Inc. generated revenues of $817.3 million in Q1'24, up 3.5% year-over-year. Additionally, the volume of Clear Aligner cases increased by 2.4% to 605.1 thousand cases during the quarter.

Q1'24 Imaging Systems and CAD/CAM Services

Align Technology Inc.'s Imaging Systems and CAD/CAM Services segment saw a robust revenue increase of 17.5% year-over-year, totaling $180.2 million in Q1'24. This growth highlights the strong demand and expanding market presence of Align's technology solutions in digital orthodontics and restorative dentistry.

Summarized from source with an LLMView Source

Key figures

-22.2%1Y
-64.8%3Y
43.9%5Y

Performance

48.1%1Y
52.1%3Y
53.6%5Y

Volatility

Market cap

18910 M

Market cap (USD)

Daily traded volume (Shares)

329,056

Daily traded volume (Shares)

1 day high/low

262.77 / 249.47

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.50

2 votes
Performance:
starstarstarstarstar
4.50
Innovation:
starstarstarstarstar
4.00
Society:
starstarstarstarstar
4.50
Nature:
starstarstarstarstar
4.00
Luba Schoenig
Switzerland, 29 May 2024
star star star star star
The market value of the dental aligners is set for fast growth
Lea Katunaric
Switzerland, 28 May 2024
star star star star star
Seems to be gaining interest and relevance as a beauty stock. I would keep an eye on it.

EQUITIES OF THE SAME SECTOR

Cencora Inc
Cencora Inc Cencora Inc Valor: 1212868
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.58%USD 228.48
Resmed Inc
Resmed Inc Resmed Inc Valor: 321632
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.12%USD 238.03
MEDICLIN AG
MEDICLIN AG MEDICLIN AG Valor: 1158721
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.71%EUR 2.38
International Flavors & Fragrances Inc
International Flavors & Fragrances Inc International Flavors & Fragrances Inc Valor: 941876
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.73%USD 103.46
Vita 34 AG
Vita 34 AG Vita 34 AG Valor: 2333201
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.93%EUR 4.40
Baxter International Inc
Baxter International Inc Baxter International Inc Valor: 911702
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.11%USD 39.37
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc West Pharmaceutical Services Inc Valor: 112491
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.50%USD 309.18
Molina Healthcare Inc
Molina Healthcare Inc Molina Healthcare Inc Valor: 1538184
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.59%USD 355.15
Quest Diagnostics Inc
Quest Diagnostics Inc Quest Diagnostics Inc Valor: 566162
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.06%USD 155.48
Bio-Rad Laboratories Inc
Bio-Rad Laboratories Inc Bio-Rad Laboratories Inc Valor: 912793
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.04%USD 340.45